CN1199664C - Chinese medicine for treating cardiovascular and cerebrovascular diseases and its preparing process - Google Patents
Chinese medicine for treating cardiovascular and cerebrovascular diseases and its preparing process Download PDFInfo
- Publication number
- CN1199664C CN1199664C CN 01129112 CN01129112A CN1199664C CN 1199664 C CN1199664 C CN 1199664C CN 01129112 CN01129112 CN 01129112 CN 01129112 A CN01129112 A CN 01129112A CN 1199664 C CN1199664 C CN 1199664C
- Authority
- CN
- China
- Prior art keywords
- extract
- chinese medicine
- radix salviae
- gram
- salviae miltiorrhizae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases and a manufacture method thereof. The effective ingredients of red sage root, ginkgo leaf and astragalus root are extracted and made into the preparation according to a certain formula and proportion. The preparation integrates the respective functions of the three kinds of medicines on treating cardiovascular and cerebrovascular diseases, and has the efficacy of promoting blood circulation, eliminating blood stasis, building up vital energy, and activating channels; the preparation can treat coronary heart disease, angina pectoris, senile dementia, cerebral thrombosis and other cardiovascular and cerebrovascular diseases. The provided preparing method is simple, the effective ingredients of the medicines can not be destroyed and can be completely utilized, and the production cost is saved.
Description
The present invention is a kind of Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof, belongs to technical field of medicaments.
Cardiovascular and cerebrovascular disease is a kind of frequently-occurring disease, commonly encountered diseases, existing Drug therapy generally is to take independent Chinese medicine product, such as: the Radix Salviae Miltiorrhizae goods, Semen Ginkgo goods etc., because these medicines are generally the single preparation, so there is not the usefulness of Comprehensive Treatment, therapeutic effect is undesirable, can only alleviate suffering from symptom, there is not special obvious treatment effect, Radix Salviae Miltiorrhizae mainly contains for the pharmacological action of cardiovascular and cerebrovascular vessel: coronary blood flow increasing, accelerate the periphery microcirculation blood flow, and increase the open number of capillary bed, improve heart merit and dwindle infarction size, antithrombotic, effects such as anti-cardiac-cerebral ischemia and accent blood fat; The Radix Astragali mainly contains for the pharmacological action of cardiovascular and cerebrovascular vessel: increase coronary flow and myocardial oxygen consumption, improve cardiac function, strengthen the anti-virus ability of cardiac muscle, the metabolism of anti-anoxia ability and enhancing myocardial cell, arteriosclerosis, blood vessel dilating and hypotensive effect have protective effect for cerebral ischemia associated with hydrocephalus, blood brain barrier, the local wachte measurer of brain; Folium Ginkgo extract mainly contains for the pharmacological action of cardiovascular and cerebrovascular vessel: expansion of cerebral vascular, cerebral blood flow increasing amount, reduce vascular resistance, also reduce cardiac muscular tension-time index, improve hemorheology status, blood circulation promoting, suppress thrombosis, alleviate cerebral hypoxia ischemia and cerebral edema, medium etc. affects the nerves; The medicines that utilize this three flavor two in Chinese medicine flavor to produce the in the prior art use of having gone on the market, such as: heart Yuan capsule, NAOLUOTONG JIAONANG etc.; But through the retrieval in State Administration of Traditional Chinese Medicine China Chinese medicine documentation retrieval centre, " not finding by Folium Ginkgo, Radix Salviae Miltiorrhizae, the Radix Astragali three flavor medicines is that prescription is declared new drug or declared the bibliographical information of Chinese medicine health care product patent ".
The objective of the invention is to: a kind of Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof is provided, this medicine is that Radix Salviae Miltiorrhizae, Folium Ginkgo, this three active ingredient of distinguishing the flavor of Chinese medicine of the Radix Astragali are become preparation according to certain prescription, ratio making after extracting, medicine combines this three flavors Chinese medicine separately for the function of people body-centered, cerebrovascular disease therapy, have the only effect of the stasis of blood, invigorating qi and dredging collateral of invigorating blood circulation, can treat cardiovascular and cerebrovascular diseases such as coronary heart disease, angina pectoris and alzheimer disease, cerebral thrombosis; The formulation method that is provided is simple, can not destroy active ingredient in the medical material, can utilize the medical material active ingredient fully, saves production cost.
The present invention constitutes like this: the Chinese medicine preparation of treatment cardiovascular and cerebrovascular disease is that 800-1400 is restrained Radix Salviae Miltiorrhizae, and 600-1200 restrains the Radix Astragali, extracts wherein active ingredient respectively after the processing of 600-1200 gram Folium Ginkgo process, is made into 1000 preparations; Say accurately: with 1200 gram Radix Salviae Miltiorrhizaes, the 1000 gram Radixs Astragali, 1000 gram Folium Ginkgos extract wherein active ingredient respectively after processing, be made into 1000 preparations; Be to improve therapeutic effect, can also be outside Radix Salviae Miltiorrhizae, the Radix Astragali, Folium Ginkgo extract, simultaneously or add a certain amount of Radix Ginseng, Radix Notoginseng respectively; The manufacture method of the Chinese medicine preparation of this treatment cardiovascular and cerebrovascular disease, be to use the alcohol heating reflux of 95-100% to extract the Radix Salviae Miltiorrhizae of aforementioned proportion, concentrate the tanshinol extract, medicinal residues are kept somewhere standby, get existing alcohol extraction----the resin method technology of Folium Ginkgo utilization and extract the Semen Ginkgo extrac (GBE) that obtains compositions such as apricot yellow ketone of argentiferous and bilobalide, adding decocting in water after Radix Salviae Miltiorrhizae decoction dregs and the Radix Astragali merging, ethanol will be added behind the liquid filtering, transfer to and contain ethanol 60-70%, technical finesse obtains extractum routinely, at last the tanshinol extract that obtains, Semen Ginkgo extrac and extractum merge, mix homogeneously is made powder after the oven dry, incapsulate; The present invention also can utilize prior art to extract tanshinone from Radix Salviae Miltiorrhizae, extracts astragaloside from the Radix Astragali, extract ginkgetin and bilobalide from Folium Ginkgo, it is mixed into paste, be made into soft capsule or drop pill, make medicine preparation more perfect like this, improve its effective percentage, satisfy different patient demands.
Compared with prior art: medicine of the present invention has the function of blood circulation promoting and blood stasis dispelling, invigorating qi and dredging collateral, can treat cardiovascular and cerebrovascular diseases such as coronary heart disease, angina pectoris and alzheimer disease, cerebral thrombosis; The formulation method that is provided is simple, can not destroy active ingredient in the medical material, can utilize the medical material active ingredient fully, saves production cost; In product, make full use of prescription medical material effect separately, can coronary blood flow increasing, accelerate the periphery microcirculation blood flow, increase the open number of capillary bed, improve heart merit and dwindle infarction size, antithrombotic, anti-cardiac-cerebral ischemia and transfer blood fat; Increase myocardial oxygen consumption; improve cardiac function; strengthen the anti-virus ability of cardiac muscle, the metabolism of anti-anoxia ability and enhancing myocardial cell, arteriosclerosis, blood vessel dilating; for cerebral ischemia associated with hydrocephalus, blood brain barrier, the local wachte measurer of brain protective effect is arranged; the cerebral blood flow increasing amount reduces vascular resistance, also reduces cardiac muscular tension-time index; improve hemorheology status, blood circulation promoting, suppress thrombosis, alleviate cerebral hypoxia ischemia and cerebral edema, medium etc. affects the nerves.
Embodiments of the invention 1: the alcohol heating reflux of 1200 gram Radix Salviae Miltiorrhizaes with 95-100% extracted, concentrate the tanshinol extract, medicinal residues are kept somewhere standby, get 1000 gram Folium Ginkgo dryings, pulverize, use the alcohol reflux of 50-70% then, utilize prior art to extract the Semen Ginkgo extrac (GBE) that obtains compositions such as apricot yellow ketone of argentiferous and bilobalide, adding decocting in water after Radix Salviae Miltiorrhizae decoction dregs and the 1000 gram Radixs Astragali merging, ethanol will be added behind the liquid filtering, transfer to and contain ethanol 60-70%, technical finesse obtains extractum routinely, at last the tanshinol extract that obtains, Semen Ginkgo extrac and extractum merge, mix homogeneously, make powder after the oven dry, in 1000 capsules of packing into.
Embodiments of the invention 2: the alcohol heating reflux of 800 gram Radix Salviae Miltiorrhizaes with 95-100% extracted, concentrate the tanshinol extract, medicinal residues are kept somewhere standby, get existing alcohol extraction----the resin method technology of 1200 gram Folium Ginkgo utilizations and extract the Semen Ginkgo extrac (GBE) that obtains compositions such as apricot yellow ketone of argentiferous and bilobalide, adding decocting in water after Radix Salviae Miltiorrhizae decoction dregs and the 600 gram Radixs Astragali merging, ethanol will be added behind the liquid filtering, transfer to and contain ethanol 60-70%, carry out precipitate with ethanol, obtain extractum, at last the tanshinol extract that obtains, Semen Ginkgo extrac and extractum merge, mix homogeneously is made powder after the oven dry, incapsulate 1000.
Embodiments of the invention 3: get 1200 gram Radix Salviae Miltiorrhizaes, the 1000 gram Radixs Astragali, 1000 gram Folium Ginkgos utilize prior art to extract from Radix Salviae Miltiorrhizae, isolate tanshinone, extract astragalus polysaccharides and astragaloside from the Radix Astragali, extract ginkgetin and bilobalide from Folium Ginkgos, it is mixed into paste, is made into soft capsule or drop pill.
Embodiments of the invention 4: in embodiment 1,2 provided by the invention, add an amount of chippy Radix Notoginseng powder and Radix Notoginseng powder and Radix Ginseng powder's mixture respectively.Improve the effect of treatment like this, strengthen patient's body constitution.
Claims (4)
1, a kind of Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease is characterized in that: 800-1400 is restrained Radix Salviae Miltiorrhizae, and 600-1200 restrains the Radix Astragali, and 600-1200 gram Folium Ginkgo extracts wherein active ingredient respectively after processing, be made into 1000 preparations.
2, according to the Chinese medicine preparation of the described this treatment cardiovascular and cerebrovascular disease of claim 1, it is characterized in that: with 1200 gram Radix Salviae Miltiorrhizaes, the 1000 gram Radixs Astragali, 1000 gram Folium Ginkgos extract wherein active ingredient respectively after processing, be made into 1000 preparations.
3, the manufacture method of Chinese medicine preparation as claimed in claim 1 or 2, it is characterized in that: the alcohol heating reflux of Radix Salviae Miltiorrhizae with 95-100% extracted, concentrate the tanshinol extract, medicinal residues are kept somewhere standby, get existing alcohol extraction----the resin method technology of Folium Ginkgo utilization and extract the Semen Ginkgo extrac (GBE) that obtains compositions such as apricot yellow ketone of argentiferous and bilobalide, adding decocting in water after Radix Salviae Miltiorrhizae decoction dregs and the Radix Astragali merging, ethanol will be added behind the liquid filtering, transfer to and contain ethanol 60-70%, technical finesse obtains extractum routinely, at last the tanshinol extract that obtains, Semen Ginkgo extrac and extractum merge, mix homogeneously is made powder after the oven dry, incapsulate.
4, according to the manufacture method of the described Chinese medicine preparation of claim 3, it is characterized in that: utilize prior art from Radix Salviae Miltiorrhizae, to extract tanshinone, from the Radix Astragali, extract astragaloside, from Folium Ginkgo, extract ginkgetin and bilobalide, it is mixed into paste, is made into soft capsule or drop pill.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01129112 CN1199664C (en) | 2001-11-23 | 2001-11-23 | Chinese medicine for treating cardiovascular and cerebrovascular diseases and its preparing process |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01129112 CN1199664C (en) | 2001-11-23 | 2001-11-23 | Chinese medicine for treating cardiovascular and cerebrovascular diseases and its preparing process |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1369289A CN1369289A (en) | 2002-09-18 |
CN1199664C true CN1199664C (en) | 2005-05-04 |
Family
ID=4668907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 01129112 Expired - Fee Related CN1199664C (en) | 2001-11-23 | 2001-11-23 | Chinese medicine for treating cardiovascular and cerebrovascular diseases and its preparing process |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1199664C (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1263472C (en) * | 2002-11-29 | 2006-07-12 | 张永 | Gingko drop pill for prevention and treatment of cardiovascular and cerebrovascular disease |
CN1305405C (en) * | 2004-12-09 | 2007-03-21 | 桂林莱茵生物制品有限公司 | Health food with subsidiary function of lowering blood sugar and lowering blood fat and its production process |
CN103083400A (en) * | 2013-03-01 | 2013-05-08 | 云南郡筹制药有限公司 | Drug for treating cardiovascular disease |
CN103316302A (en) * | 2013-07-08 | 2013-09-25 | 陈静静 | Chinese medicine formula for treating angina pectoris |
CN105380996B (en) * | 2015-11-10 | 2021-02-02 | 石任兵 | Traditional Chinese medicine composition with blood circulation promoting and bleeding stopping effects and preparation thereof |
CN105687492A (en) * | 2016-04-13 | 2016-06-22 | 陈文洪 | Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases |
CN107759654B (en) * | 2017-10-27 | 2020-02-21 | 中国科学院成都生物研究所 | Application of astragaloside and derivatives thereof in preparation of antithrombotic drugs |
CN108066645A (en) * | 2017-12-14 | 2018-05-25 | 芜湖市诺康生物科技有限公司 | A kind of preparation method of ginkgo leaf capsule of red sage root |
CN115089655B (en) * | 2022-05-12 | 2023-09-08 | 北京宜生堂医药科技研究有限公司 | Traditional Chinese medicine composition for treating Alzheimer's disease, extract, preparation method and application |
-
2001
- 2001-11-23 CN CN 01129112 patent/CN1199664C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1369289A (en) | 2002-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1994451B (en) | Chinese medicinal composition for treating depression, its preparation method and application | |
CN101229312A (en) | Medicine compounds capable of regulating hypertension, hyperlipemia and angina | |
CN101168042A (en) | Traditional Chinese medicine preparation for curing cardiovascular and cerebrovascular diseases and preparing method | |
CN101502588B (en) | Composition for beauty treatment and removing blain and method for preparing the same | |
CN115770279B (en) | Traditional Chinese medicine composition for treating chronic lower limb vein diseases, decoction and preparation thereof | |
CN1199664C (en) | Chinese medicine for treating cardiovascular and cerebrovascular diseases and its preparing process | |
CN1222298C (en) | Medicine for treating cardiovascular disease | |
CN102284022A (en) | Cough medicament and preparation method thereof | |
CN101347557B (en) | Medicament composition for refreshment and intelligence development and preparation and use thereof | |
CN102225100A (en) | Chinese medicinal formulation for treating cardiovascular and cerebrovascular diseases and preparation process of products thereof | |
CN101953918A (en) | Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases | |
CN103479691A (en) | Lipid-decreasing liver protection traditional Chinese medicine composition | |
CN100488539C (en) | Pharmaceutical composition for promoting blood circulation and preparation method thereof | |
CN101152243B (en) | Traditional Chinese medicine for treating apoplexy and technique of preparing the same | |
CN111643605A (en) | A Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and its preparation method | |
CN105456390A (en) | Clinical mixed preparation for cardiovascular department and preparation method | |
CN102293985B (en) | Traditional Chinese medicine composition used for treating coronary heart disease and preparation method thereof | |
CN109172608B (en) | A kind of Chinese medicine composition that can improve sleep quality | |
CN101313989B (en) | Chinese medicinal composition for treating coronary disease, stenocardia | |
CN105362630A (en) | Climacteric syndrome treatment pharmaceutical composition and preparation method thereof | |
CN1321484A (en) | Medicine for curing coronary heart disease with hypertension and its preparation process | |
CN1067260C (en) | Pure Chinese drug tangniaojing for curing diabetes | |
CN103479744A (en) | Traditional Chinese medicine composition with functions of soothing liver and maintaining beauty | |
CN113577137B (en) | Traditional Chinese medicine composition for treating acne and preparation method and application thereof | |
CN107496876A (en) | A kind of eliminating embolism and invigorating blood circulation Chinese medicine preparation and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |